Keyword : systemic diseases of the connective tissue
TO THE QUESTION OF THE POSSIBILITY AND ACCEPTABILITY OF USING OFF-LABEL DRUGS IN PEDIATRIC RHEUMATOLOGY ACCORDING TO EXPERIENCE WITH RITUXIMAB IN CHILDREN WITH SYSTEMIC CONNECTIVE TISSUE DISEASES THAT ARE RESISTANT TO THERAPY
Authors: Oshlianska O.A. Оmelchenko L.I. №81 (3) 2020 / Review: 24
Authors: Oshlianska O.A. Оmelchenko L.I. №81 (3) 2020 / Review: 24